Journal of
eISSN: 2373-633X
Submit manuscript...
Clinical Paper Volume 17 Issue 4
Prevalence and manifestations of HER2-low breast cancer in patients with unresectable and/or metastatic disease progressing on anticancer therapy: a retrospective study in the GCC region
Shereef Elsamany, Salha BJ Al Bader, Abdullah Altwairgi, Abdulwahab Altourah, Aref Chehal, Aydah AlAwadhi, Diaeddine Trad, Fathi Azribi, Mishari Alzahrani, Syed Hammad Tirmazy, Sharif Kullab, Syed Hammad Tirmazy, Mai Behairy, Amgad Kamal
National Center for Cancer Care and Research, Doha, Qatar.
AstraZeneca Gulf Cooperation Council, Dubai, UAE
King Abdullah Medical City, Makkah, KSA
King Fahad Medical City, Riyadh, KSA
Kuwait Cancer Control Center, Kuwait
Sheikh Shakhbout Medical City, Abu Dhabi, UAE
Tawam Hospital, Al Ain, UAE
American Hospital, Dubai, UAE
King Faisal Specialist Hospital and Research Center, Riyadh, KSA
Dubai Hospital, Dubai, UAE
King Khaled University Hospital, Riyadh, KSA
Received: June 24, 2026 | Published: August 11, 2026
Citation: Bader SBJA, Altwairgi A, Altourah A, et al. Prevalence and manifestations of HER2-low breast cancer in patients with unresectable and/or metastatic disease progressing on anticancer therapy: a retrospective study in the GCC region. J Cancer Prev Curr Res. 2026;17(4):128‒137 DOI: 10.15406/jcpcr.2026.17.00620
©2026 Bader, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.